Comparison of tumor assessments using RECIST 1.1 and irRECIST, and association with overall survival by James L Gulley, Sandra P D'Angelo, Marcis Bajars, Andrea B Apolo, Juliane Manitz, S Peter Eggleton, Oliver Bohnsack

Get full text

Efficacy and immune-related adverse event associations in avelumab-treated patients by Arun Rajan, James L Gulley, Manish R Patel, Vijay Kasturi, Karen Kelly, Marcis Bajars, Andrea B Apolo, Juliane Manitz, Sandra P D’Angelo, Isabell Speit, John Warth

Get full text

Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial by Celeste Lebbe, Omid Hamid, Shailender Bhatia, Janice M Mehnert, Patrick Terheyden, Michele Milella, Isaac Brownell, Sandra P D'Angelo, Andrew S Brohl, Kent C Shih, Karl D Lewis, Gerald P Linette, Sara Georges, Parantu Shah, Barbara Ellers-Lenz, Marcis Bajars, Gülseren Güzel, Paul T Nghiem

Get full text